The World Congress Summit on Patient Centricity and Advocacy

Biopharma and device manufacturers are taking great measures to include the voice of the patient in all aspects of the drug development process – from pre-clinical to commercial. While being truly patient centric requires an organization-wide commitment and patient focused employees in every department, strong partnerships with advocacy groups serve as a solid foundation for this paradigm shift. This summit brings together manufacturer and advocacy professionals to discuss how to most effectively engage the patient in drug development and communication strategies, what areas are the most ripe for collaboration, and to share strategies and results from successful case examples.

Top Reasons To Attend:

• Gain insights from the preliminary findings on the FDA-Duke collaborative Clinical Trials Transformation Initiative case study on best practices for effective Engagement with patient groups around clinical trials
• Hear directly from E-Patient, Christel Aprigliano, the role that e-patients play and how to effectively engage with them
• National Health Council Associate Vice President Eric Gauscho gives a look into the future of defining patient outcomes and how that will be managed in the future
• Join the discussion with our distinguished panelists as they discuss some successful strategies for overcoming challenges in partnerships that have arisen between industry and advocacy
• Understand patients as people by collaborating and partnering with physician groups and integrated health care systems
• Bring traditional relationships to the digital space—learn how to effectively use social media to engage patients and patient groups

Call for Papers: Submit Abstract for Presentations The World Congress Patient Advocacy and Engagement Summit is now accepting abstract submissions for 2015! Deadline is May 22, 2015. Click here for details.